- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- Lung
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
My oncology training was undertaken at St. Bartholomew’s, UCLH and Mount Vernon Hospitals. Following my Fellowship, I undertook a postgraduate research degree at Imperial College School of Medicine, Hammersmith Hospital. There I investigated the potential for Positron Emission Tomography (PET) to demonstrate the biological effects of chemotherapy in tissue.
I have published a number of papers in this area and was awarded a PhD for my work. Subsequently I completed my post doctoral training at the Royal Marsden Hospital, principally with the Academic Urology Unit.
I specialise in the management of patients with genitourinary (bladder and prostate) and thoracic (lung and mesothelioma) malignancies. Furthermore I have significant expertise in the delivery of real time dynamic prostate low dose rate (LDR) brachytherapy for patients with early stage, localised prostate cancer. I am also a registered Cyberknife practitioner with a National referral practice and deliver stereotactic radiotherapy (SABR) in both the radical and palliative (for metastatic disease) setting.
Since taking up my present post I have been extensively involved with the development of the genitourinary and thoracic cancer services for the North East London Cancer Network and London Cancer.
I am an active participant in UK clinical trials and am principal investigator for the North East London Cancer Network for a number of studies. I introduced Intensity Modulated (IMRT) and image guided (IGRT) radiotherapy to my NHS practice in 2010, which was mirrored in my private work. I have significant experience in chemo-radiation in bladder and lung cancer and stereotactic radiotherapy for lung and prostate cancer in the radical setting and the treatment of oligometastatic disease for all tumour sites including brain. My research interest in PET continues to develop with an emphasis on investigating the direct effects of radiotherapy on tissue and the effect of integration of novel therapies with radiation.
Areas of interest
• Bladder Cancer • Prostate Cancer • Mesothelioma • Lung cancer • Cyberknife • Prostate brachytherapy; chemotherapy; targeted therapy; immunotherapy
Medical secretaries
- Jennifer Robinson
- The London Oncology Clinic 95 Harley Street LONDON W1G 6AF
- 020 7034 8689
- jennifer.robinson@hcahealthcare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
- Show All (7 )...